Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 18, 2014

View Archived Issues

Development of non-viral minicircle DNA vectors for phenylketonuria gene therapy

Auigene Discovery Technologies and UM Pharmauji report DHODH inhibitors

AAK1 inhibitors disclosed in recent BMS patent

Long-term treatment with fingolimod sustains low rates of brain volume loss in LONGTERMS trial

Immunotope licenses CaPtivate's nanoparticle technology for T-cell vaccines

OncoCyte to use Abcodia's serum bank to validate its PanC-Dx cancer diagnostic

BARDA contract supports InDevR's development of FluChip-8G influenza diagnostic

MGB Biopharma raises funding for phase I trial of novel antibacterial MGB-BP-3

ASP-2397, a natural product with potent fungicidal activity

TapImmune reports interim data from phase I trial of folate receptor alpha antigens

FDA assigns orphan drug designation to various cancer therapies under development

Novel potent inhibitors of histone demethylase KDM1A for epigenetic-related cancer therapy

Oncolytics reports progression-free survival data from trial of Reolysin in pancreatic cancer

In vitro and in vivo bone anabolic effects of P2X7 receptor blocker AFC-5261

Alnylam Pharmaceuticals describes siRNA for treating pre-eclampsia

Empagliflozin/linagliptin FDC shows superior efficacy to individual components

Akashi Therapeutics acquires worldwide rights to GsMTx-4

Concert Pharmaceuticals begins phase I trial of CTP-730

Sun Pharma and Merck & Co. form licensing agreement for tildrakizumab

Prezcobix launched in Canada for HIV

Otsuka Pharmaceutical receives approval for BCR-ABL mRNA measurement kit

Parion Sciences receives award from Cystic Fibrosis Foundation Therapeutics

CTI BioPharma and Servier to develop and commercialize Pixuvri

NicOx to acquire French ophthalmic company Doliage

BioBlast Pharma reports data from several studies of Cabaletta

FDA places clinical hold on phase IIb study of Flexion's FX-006 for knee osteoarthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 7, 2025.
House passes H.R. 1, restoring R&D tax cuts
BioWorld MedTech
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
With surface mimicry, molecular glues shed hairpin need
BioWorld Science
Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...